|
|
|
News for Food and Drug Administration (FDA)News > FDAListings 341 - 350 of 475:
Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
Wyeth Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has issued an approvable letter for bazedoxifene, a selective estroge...
David Bloch Joins King & Spalding as an FDA Regulatory Partner
King & Spalding, an international law firm, announced that David J. Bloch, a regulatory lawyer with significant experience counseling pharmaceutical, ...
AACR, FDA And NCI Announce Cancer Biomarkers Collaborative
The American Association for Cancer Research, together with the Food and Drug Administration and National Cancer Institute, have announced the formati...
Caraco Pharmaceutical Laboratories Ltd. Announces FDA Approval to Market Generic Ambien
Caraco Pharmaceutical Laboratories announced that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated N...
FDA Announces Audio Broadcasts on Emerging Drug Safety Information
The U.S. Food and Drug Administration (FDA) is alerting health care professionals and consumers to the availability of audio broadcasts that provide e...
FDA Approves Alpharma's KADIAN New 10mg Strength
Alpharma, a global specialty pharmaceutical company, today announced that it has been notified by the United States Food and Drug Administration("FDA"...
More Than 25 Healthcare Organizations Rely on Vernier Networks’ NAC Appliances to Bolster Security and HIPAA Compliance
Vernier Networks, supplier of award-winning network access control (NAC) appliances, has recently added more than 25 healthcare organizations to its g...
NMT Medical Receives FDA Approval for Modifications in Pivotal U.S. PFO/Stroke Trial
NMT Medical, an advanced medical technology company that designs, develops,manufactures and markets proprietary implant technologies that allow interv...
Oral Azacitidine Advances to Multi-Center, Multi-Cycle, Dose Escalation Study
Pharmion Corporation announced that the multi-center, open label Phase 1 clinical trial of single dose oral azacitidine in patients with MDS, AML and ...
Pharmacyclics Announces FDA Filing of New Drug Application for Xcytrin Injection to Treat Lung Cancer Brain Metastases
Pharmacyclics announced that the U.S. Food and Drug Administration (FDA) has filed the company's New Drug Application (NDA) for Xcytrin (motexafin gad... |
|
|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |